Biolife solutions announces fourth quarter and full year 2020 financial results

Bothell, wash., march 22, 2021 /prnewswire/ --  biolife solutions , inc. (nasdaq: blfs) ("biolife" or the "company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced financial results for the fourth quarter and year ended december 31, 2020.
BLFS Ratings Summary
BLFS Quant Ranking